Back

Preterm birth, abnormal foetal growth and the risk of atrial fibrillation later in life: a cohort study in Denmark, Finland and Sweden

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Individual treatment strategies in atrial fibrillation Epidemiology ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Miss Fen Yang

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Fish oil supplements increase atrial fibrillation risk in healthy individuals: a population-based cohort study and mendelian randomization analysis
Doctor H. Ahn (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes in patients with atrial fibrillation with or without concomitant diabetes after two years of edoxaban treatment: ETNA-AF-Europe registry
Professor G. Patti (Novara, IT)
Abstract Slides Video
Presentation thumbnail
The AFLETES study: atrial fibrillation in veteran athLETEs and the risk of stroke
Doctor S. Pallikadavath (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
Heart failure and cardiovascular outcomes in european patients with atrial fibrillation
Doctor N. Bonini (Modena, IT)
Abstract Slides Video
Presentation thumbnail
The comorbidity network in older adults with atrial fibrillation: a danish nationwide cohort study
Doctor L. Dai (Stockholm, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Individual treatment strategies in atrial fibrillation

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Predicting atrial fibrillation from ECG characteristics
thumbnail
Congress Presentation
Prognostic implications of atrial fibrillation in young patients without overt heart disease - an early marker of future cardiomyopathy ?
thumbnail
Congress Presentation
Temporal and age-related trends in risk factors for development of atrial fibrillation in peripartum patients

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources